-
ACORQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Acorda Therapeutics (ACORQ)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.34 mm | 10.34 mm | 10.34 mm | 10.34 mm | 10.34 mm | 10.34 mm |
Cash burn (monthly) | 6.76 mm | 2.28 mm | 9.09 mm | 25.37 mm | 6.73 mm | 2.26 mm |
Cash used (since last report) | 74.88 mm | 25.31 mm | 100.75 mm | 281.06 mm | 74.54 mm | 25.07 mm |
Cash remaining | -64.55 mm | -14.97 mm | -90.41 mm | -270.73 mm | -64.20 mm | -14.73 mm |
Runway (months of cash) | -9.5 | -6.6 | -9.9 | -10.7 | -9.5 | -6.5 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 17 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|